BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 12549511)

  • 1. [Genetic mutation in head and neck squamous cell carcinoma].
    Shiga K
    Nihon Jibiinkoka Gakkai Kaiho; 2002 Oct; 105(10):1059-64. PubMed ID: 12549511
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetic profile of head and neck squamous cell carcinoma: clinical implications.
    Agada FO; Patmore H; Alhamarneh O; Stafford ND; Greenman J
    J Laryngol Otol; 2009 Mar; 123(3):266-72. PubMed ID: 18694533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognostic factors for head and neck cancer].
    Fujieda S
    Gan To Kagaku Ryoho; 2001 Apr; 28(4):440-7. PubMed ID: 11329776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression profiling in head and neck squamous cell carcinoma: Clinical perspectives.
    Lallemant B; Evrard A; Chambon G; Sabra O; Kacha S; Lallemant JG; Lumbroso S; Brouillet JP
    Head Neck; 2010 Dec; 32(12):1712-9. PubMed ID: 20949446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of heterozygosity and mutation analysis of the p16 (9p21) and p53 (17p13) genes in squamous cell carcinoma of the head and neck.
    González MV; Pello MF; López-Larrea C; Suárez C; Menéndez MJ; Coto E
    Clin Cancer Res; 1995 Sep; 1(9):1043-9. PubMed ID: 9816078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correspondence re: F. Coulet et al., Detection of plasma tumor DNA in head and neck squamous cell carcinoma by microsatellite typing and p53 mutation analysis. Cancer Res., 60: 707-709, 2000.
    Silva JM; Bonilla F
    Cancer Res; 2001 Dec; 61(23):8595-6. PubMed ID: 11731447
    [No Abstract]   [Full Text] [Related]  

  • 7. Aurora sheds light on head and neck squamous cell carcinoma.
    Han H; Von Hoff DD
    Clin Cancer Res; 2006 Sep; 12(17):5003-4. PubMed ID: 16951211
    [No Abstract]   [Full Text] [Related]  

  • 8. Head and neck cancer and precancer: can we use molecular genetics to make better predictions?
    Partridge M
    Ann R Coll Surg Engl; 1999 Jan; 81(1):1-11. PubMed ID: 10325677
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical applications of the diagnosis of p53 alterations in squamous cell carcinoma of the head and neck.
    Lopez-Martinez M; Anzola M; Cuevas N; Aguirre JM; De-Pancorbo M
    Med Oral; 2002; 7(2):108-20. PubMed ID: 11887018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck.
    Brennan JA; Boyle JO; Koch WM; Goodman SN; Hruban RH; Eby YJ; Couch MJ; Forastiere AA; Sidransky D
    N Engl J Med; 1995 Mar; 332(11):712-7. PubMed ID: 7854378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognostic factors in squamous cell carcinomas of the head and neck].
    Faye-Lund H
    Tidsskr Nor Laegeforen; 1998 Aug; 118(18):2785-7. PubMed ID: 9748809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of molecular markers and gene profiling in head and neck cancers.
    Gold KA; Kim ES
    Curr Opin Oncol; 2009 May; 21(3):206-11. PubMed ID: 19346943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of head and neck squamous cell carcinoma among exfoliated oral mucosal cells by microsatellite analysis.
    Spafford MF; Koch WM; Reed AL; Califano JA; Xu LH; Eisenberger CF; Yip L; Leong PL; Wu L; Liu SX; Jerónimo C; Westra WH; Sidransky D
    Clin Cancer Res; 2001 Mar; 7(3):607-12. PubMed ID: 11297256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of plasma tumor DNA in head and neck squamous cell carcinoma by microsatellite typing and p53 mutation analysis.
    Coulet F; Blons H; Cabelguenne A; Lecomte T; Lacourreye O; Brasnu D; Beaune P; Zucman J; Laurent-Puig P
    Cancer Res; 2000 Feb; 60(3):707-11. PubMed ID: 10676657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent deletion and down-regulation of ING4, a candidate tumor suppressor gene at 12p13, in head and neck squamous cell carcinomas.
    Gunduz M; Nagatsuka H; Demircan K; Gunduz E; Cengiz B; Ouchida M; Tsujigiwa H; Yamachika E; Fukushima K; Beder L; Hirohata S; Ninomiya Y; Nishizaki K; Shimizu K; Nagai N
    Gene; 2005 Aug; 356():109-17. PubMed ID: 15935570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No germline mutations in CDKN2A (p16) in patients with squamous cell cancer of the head and neck and second primary tumours.
    Jefferies S; Edwards SM; Hamoudi RA; A'Hern R; Foulkes W; Goldgar D; Eeles R;
    Br J Cancer; 2001 Nov; 85(9):1383-6. PubMed ID: 11720478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implications.
    Tabor MP; Brakenhoff RH; van Houten VM; Kummer JA; Snel MH; Snijders PJ; Snow GB; Leemans CR; Braakhuis BJ
    Clin Cancer Res; 2001 Jun; 7(6):1523-32. PubMed ID: 11410486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can molecular assessment improve classification of head and neck premalignancy?
    Mao L
    Clin Cancer Res; 2000 Feb; 6(2):321-2. PubMed ID: 10690505
    [No Abstract]   [Full Text] [Related]  

  • 19. Allelotype of head and neck squamous cell carcinoma.
    Nawroz H; van der Riet P; Hruban RH; Koch W; Ruppert JM; Sidransky D
    Cancer Res; 1994 Mar; 54(5):1152-5. PubMed ID: 8118797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary squamous cell carcinoma following head and neck squamous cell carcinoma: metastasis or second primary?
    Geurts TW; Nederlof PM; van den Brekel MW; van't Veer LJ; de Jong D; Hart AA; van Zandwijk N; Klomp H; Balm AJ; van Velthuysen ML
    Clin Cancer Res; 2005 Sep; 11(18):6608-14. PubMed ID: 16166439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.